September 30, 2015
While “personalized medicine” in the broadest sense has been a part of medical care for a very long time, the past decade has witnessed an explosion of genetic testing to treat a variety of conditions, most notably oncology therapies. The adage of “getting the right drug to the right patient at the right time” has never been more applicable. But it can be challenging for providers to determine which tests provide clinical value in treating a condition. And as payers strain to make the most of their health care dollars, they need strategies for measuring the cost-effectiveness of genetic testing. Hear two of the industry’s most knowledgeable genetic testing professionals discuss strategies providers and payers are developing to make personalized medicine a WIN-WIN-WIN for patients, providers and health plans.
Event Details Available Here.
